GL1X · GenesisL1 explorer

Research workbench

Human gar transformylase in complex with gar substrate and AGF131 inhibitor

Analyse Human gar transformylase in complex with gar substrate and AGF131 inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7JG4
Type
protein
Length
200 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Trifunctional purine biosynthetic protein adenosine-3
EC
6.3.4.13, 6.3.3.1, 2.1.2.2
UniProt
P22102
Ligands
GAR, V9V, NA
Pockets
1 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATrifunctional purine biosynthetic protein adenosine-3 (EC 6.3.4.13, 6.3.3.1, 2.1.2.2)protein20036% helix, 24% strandP22102

Ligands and binding sites

  • GAR · Glycinamide ribonucleotide · ligand · chains A
  • V9V · N-(5-{3-[(1S,7R,8R,9S)-4-amino-2-oxo-7lambda~4~-thia-3, 5-diazatetracyclo[4.3.0.0~1,7~.0~7,9~]nona-3,5-dien-8-yl]propyl}thiophene-2-carbonyl)-L-glutamic acid · ligand · chains A
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13270.640.8041GAR, V9V, NA

Compared structures

  • 7JG4 · Human GAR transformylase in complex with GAR substrate and AGF131 inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P22102 · AlphaFold monomer V2.0 prediction for trifunctional purine biosynthetic protein… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.